BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35090397)

  • 21. Computed Tomography-X Ray Fusion in Left Atrial Appendage Closure.
    Barreiro-Pérez M; Cruz-González I; Sánchez PL
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):867. PubMed ID: 28274702
    [No Abstract]   [Full Text] [Related]  

  • 22. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
    Lempereur M; Aminian A; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Cruz-Gonzalez I; Kanagaratnam P; Nietlispach F; Ibrahim R; Sievert H; Schillinger W; Park JW; Gloekler S; Tzikas A
    Am J Cardiol; 2017 Aug; 120(3):414-420. PubMed ID: 28595859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left atrial appendage closure: A single center experience and comparison of two contemporary devices.
    Figini F; Mazzone P; Regazzoli D; Porata G; Ruparelia N; Giannini F; Stella S; Ancona F; Agricola E; Sora N; Marzi A; Aurelio A; Trevisi N; Della Bella P; Colombo A; Montorfano M
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):763-772. PubMed ID: 27567013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Atrial Appendage Closure: Therapy Overview and Future Perspective.
    Nasr GH; Rushworth PM; Donaldson DM
    Cardiol Clin; 2024 Aug; 42(3):389-401. PubMed ID: 38910023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and characteristics of candidates for percutaneous left atrial appendage occlusion using a WATCHMAN device among patients who underwent atrial fibrillation ablation in a Japanese population.
    Kemi Y; Yamashita E; Fujiwara T; Kario K; Sasaki T; Minami K; Miki Y; Goto K; Take Y; Nakamura K; Naito S
    J Echocardiogr; 2021 Dec; 19(4):243-249. PubMed ID: 34296416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation.
    Vrana E; Kartas A; Samaras A; Vasdeki D; Forozidou E; Liampas E; Karvounis H; Giannakoulas G; Tzikas A
    J Cardiovasc Med (Hagerstown); 2022 Mar; 23(3):176-182. PubMed ID: 34580251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
    Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left Atrial Appendage Occlusion With the LAmbre Device: Initial Experience.
    Cruz-González I; Freixa X; Fernández-Díaz JA; Moreno-Samos JC; Martín-Yuste V; Goicolea J
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):755-756. PubMed ID: 28522304
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry.
    Cruz-González I; Ince H; Kische S; Schmitz T; Schmidt B; Gori T; Foley D; de Potter T; Tschishow W; Vireca E; Stein K; Boersma LV
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):21-27. PubMed ID: 30956034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
    Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
    J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of left atrial appendage occlusion with multiple devices.
    Radinovic A; Falasconi G; Marzi A; D'Angelo G; Limite L; Paglino G; Peretto G; Frontera A; Fierro N; Sala S; Della Bella P; Mazzone P
    Int J Cardiol; 2021 Dec; 344():66-72. PubMed ID: 34599944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y
    Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Effectiveness of Percutaneous Closure of Left Atrial Appendage in Patients With Intracranial Hemorrhage.
    Cruz-González I; Rama-Merchan JC; Martínez-Peralta S; López-Mesonero L; Rodríguez-Collado J; Sánchez PL
    Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):58-60. PubMed ID: 27720416
    [No Abstract]   [Full Text] [Related]  

  • 38. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter-based closure of residual leaks after percutaneous occlusion of the left atrial appendage with WATCHMAN device: two cases.
    Torres-Saura F; Pérez-de Prado A; Romero-Vazquiánez M; Garrote-Coloma C; Pérez-Berbel P; Arroyo-Úcar E
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):262-263. PubMed ID: 31740276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.